{"disease":{"id":"platinum-resistant-squamous-cell-carcinoma-of-the-head-and-neck","name":"platinum resistant squamous cell carcinoma of the head and neck"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT01332266","title":"E7050 in Combination With Cetuximab Versus Cetuximab Alone in the Treatment of Platinum-Resistant Squamous Cell Carcinoma of the Head and Neck","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":95,"lead_sponsor_name":"Eisai Inc.","has_results":true}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}